Pricing Log in Create free account

Larimar Therapeutics, Inc. (LRMR) vs ProQR Therapeutics N.V. (PRQR)

Larimar Therapeutics, Inc. and ProQR Therapeutics N.V. are both Biotechnology companies. Larimar Therapeutics, Inc. and ProQR Therapeutics N.V. are of similar size ($206.7M and $204.6M). Larimar Therapeutics, Inc. has the higher net margin (0.00% vs −228.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, ProQR Therapeutics N.V. leads on 7 and Larimar Therapeutics, Inc. on 6.

Valuation

Metric LRMR PRQR Biotechnology median
P/E n/m n/m 8.50
P/S n/m 6.71 9.71
P/B 1.62 1.56 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 0.85 9.21
Earnings yield (97.99%) (35.11%) (33.15%)
Free cash flow yield (75.51%) (39.84%) (25.50%)

Profitability

Metric LRMR PRQR Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (233.33%) 0.00%
Net margin 0.00% (228.71%) 0.00%
Free cash flow margin 0.00% (267.36%) 0.00%
Return on equity (138.41%) (58.29%) (56.36%)
Return on assets (108.53%) (31.53%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LRMR PRQR Biotechnology median
Revenue growth (TTM) — 19.72% 6.02%
EPS growth (last fiscal year) (71.97%) (28.57%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LRMR PRQR Biotechnology median
Debt to equity 0.00 0.06 0.00
Current ratio 4.70 3.49 4.72
Net debt to EBITDA 0.79 2.15 0.96

Dividend

Metric LRMR PRQR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LRMR PRQR Biotechnology median
Market cap 206.73m 204.63m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack